Chalice Brands Ltd (CHALF)
0.0000
0.00 (0.00%)
USD |
OTCM |
May 01, 10:40
Chalice Brands Max Drawdown (5Y): 100.0% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 100.0% |
March 31, 2024 | 100.0% |
February 29, 2024 | 100.0% |
January 31, 2024 | 100.0% |
December 31, 2023 | 100.0% |
November 30, 2023 | 100.00% |
October 31, 2023 | 100.00% |
September 30, 2023 | 100.00% |
August 31, 2023 | 100.00% |
July 31, 2023 | 100.00% |
June 30, 2023 | 100.00% |
May 31, 2023 | 100.00% |
April 30, 2023 | 99.98% |
March 31, 2023 | 99.81% |
February 28, 2023 | 99.46% |
January 31, 2023 | 99.46% |
December 31, 2022 | 99.46% |
November 30, 2022 | 99.46% |
October 31, 2022 | 98.86% |
September 30, 2022 | 98.61% |
August 31, 2022 | 98.48% |
July 31, 2022 | 98.48% |
June 30, 2022 | 98.48% |
May 31, 2022 | 98.48% |
April 30, 2022 | 98.48% |
Date | Value |
---|---|
March 31, 2022 | 98.48% |
February 28, 2022 | 98.48% |
January 31, 2022 | 98.48% |
December 31, 2021 | 98.48% |
November 30, 2021 | 98.48% |
October 31, 2021 | 98.48% |
September 30, 2021 | 98.48% |
August 31, 2021 | 98.48% |
July 31, 2021 | 98.48% |
June 30, 2021 | 98.48% |
May 31, 2021 | 98.48% |
April 30, 2021 | 98.48% |
March 31, 2021 | 98.48% |
February 28, 2021 | 98.48% |
January 31, 2021 | 98.48% |
December 31, 2020 | 98.48% |
November 30, 2020 | 98.48% |
October 31, 2020 | 98.48% |
September 30, 2020 | 98.48% |
August 31, 2020 | 98.48% |
July 31, 2020 | 98.48% |
June 30, 2020 | 98.48% |
May 31, 2020 | 98.48% |
April 30, 2020 | 98.48% |
March 31, 2020 | 98.48% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
88.98%
Minimum
May 2019
100.0%
Maximum
Dec 2023
98.40%
Average
98.48%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Lexaria Bioscience Corp | 98.90% |
Liminal Biosciences Inc (DELISTED) | -- |